{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:30:36Z","timestamp":1773923436875,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.07.038","type":"journal-article","created":{"date-parts":[[2007,8,7]],"date-time":"2007-08-07T08:33:30Z","timestamp":1186475610000},"page":"7247-7260","source":"Crossref","is-referenced-by-count":51,"title":["Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Gregory A.","family":"Price","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather P.","family":"Masri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee M.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia Nau","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.07.038_bib1","series-title":"Antimicrobial resistance in Neisseria gonorrhoeae","author":"Tapsall","year":"2001"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2007.07.038_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0140-6736(98)90001-0","article-title":"Global epidemiology of sexually transmitted diseases","volume":"351","author":"Gerbase","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.07.038_bib3","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2004. Atlanta, GA: U.S. Department of Health and Human Services; 2004."},{"key":"10.1016\/j.vaccine.2007.07.038_bib4","series-title":"Mucosal immunology of sexually transmitted diseases","author":"Russell","year":"2005"},{"key":"10.1016\/j.vaccine.2007.07.038_bib5","series-title":"Gonococcal infections in the adult","author":"Hook","year":"1999"},{"key":"10.1016\/j.vaccine.2007.07.038_bib6","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2003 supplement: gonococcal isolate surveillance project (GISP) annual report 2003. Atlanta, GA: U.S. Department of Health and Human Services; 2003."},{"issue":"9069","key":"10.1016\/j.vaccine.2007.07.038_bib7","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(97)02190-9","article-title":"Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00002030-200101050-00015","article-title":"Treatment of cervicitis is associated with decreased cervical shedding of HIV-1","volume":"15","author":"McClelland","year":"2001","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.038_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0264-410X(91)90147-X","article-title":"Efficacy trial of a parenteral gonococcal pilus vaccine in men","volume":"9","author":"Boslego","year":"1991","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib10","first-page":"29","article-title":"Gonococcal vaccine studies in Inuvik","volume":"65","author":"Greenberg","year":"1974","journal-title":"Can J Public Health"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2007.07.038_bib11","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1128\/CMR.2.Suppl.S74","article-title":"Gonococcal vaccines","volume":"2","author":"Tramont","year":"1989","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2007.07.038_bib12","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1128\/IAI.68.8.4725-4735.2000","article-title":"Antigenic and sequence diversity in gonococcal transferrin-binding protein A","volume":"68","author":"Cornelissen","year":"2000","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.038_bib13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/IAI.65.2.822-828.1997","article-title":"Characterization of the diversity and the transferrin-binding domain of gonococcal transferrin-binding protein 2","volume":"65","author":"Cornelissen","year":"1997","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.038_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/IAI.63.3.884-890.1995","article-title":"Evaluation of transferrin-binding protein 2 within the transferrin-binding complex as a potential antigen for future meningococcal vaccines","volume":"63","author":"Lissolo","year":"1995","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.038_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mpat.1996.0012","article-title":"Blocking of iron uptake from transferrin by antibodies against the transferrin binding proteins in Neisseria meningitidis","volume":"20","author":"Pintor","year":"1996","journal-title":"Microb Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.038_bib16","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/IAI.69.3.1561-1567.2001","article-title":"Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection","volume":"69","author":"West","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.038_bib17","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/IAI.60.6.2391-2396.1992","article-title":"Common antigemic domains in transferrin-binding protein 2 of Neisseria meningitidis, Neisseria gonorrhoeae, and Haemophilus influenzae Type b","volume":"60","author":"Stevenson","year":"1992","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.038_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2958.1998.00710.x","article-title":"The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers","volume":"27","author":"Cornelissen","year":"1998","journal-title":"Mol Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.07.038_bib19","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1128\/IAI.73.7.3945-3953.2005","article-title":"Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice","volume":"73","author":"Price","year":"2005","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.07.038_bib20","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/154405910508401205","article-title":"Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections","volume":"84","author":"Hajishengallis","year":"2005","journal-title":"J Dent Res"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.038_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/09687680410001663267","article-title":"Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (review)","volume":"21","author":"De Haan","year":"2004","journal-title":"Mol Membr Biol"},{"issue":"19","key":"10.1016\/j.vaccine.2007.07.038_bib22","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1073\/pnas.85.19.7109","article-title":"Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro","volume":"85","author":"Hardy","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.vaccine.2007.07.038_bib23","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.4049\/jimmunol.154.9.4322","article-title":"Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2\/B subunits","volume":"154","author":"Hajishengallis","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.038_bib24","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/IAI.71.4.2272-2275.2003","article-title":"Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein","volume":"71","author":"Lee","year":"2003","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.07.038_bib25","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/IAI.72.12.7306-7310.2004","article-title":"Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis","volume":"72","author":"Li","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/IAI.69.1.252-261.2001","article-title":"Recombinant antigen-enterotoxin A2\/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells","volume":"69","author":"Martin","year":"2001","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2007.07.038_bib27","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0264-410X(01)00488-1","article-title":"Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin","volume":"20","author":"Sheoran","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.038_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/IAI.66.2.462-468.1998","article-title":"Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin","volume":"66","author":"Sultan","year":"1998","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.07.038_bib29","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.vaccine.2005.08.097","article-title":"Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection","volume":"24","author":"Singh","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.038_bib30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/JB.85.6.1274-1279.1963","article-title":"Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation","volume":"85","author":"Kellogg","year":"1963","journal-title":"J Bacteriol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.07.038_bib31","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/jb.169.8.3414-3421.1987","article-title":"Aerobactin utilization by Neisseria gonorrhoeae and cloning of a genomic DNA fragment that complements Escherichia coli fhuB mutations","volume":"169","author":"West","year":"1987","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.038_bib32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/IAI.70.2.732-740.2002","article-title":"Specific ligand binding attributable to individual epitopes of gonococcal transferrin binding protein A","volume":"70","author":"Masri","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/IAI.72.1.277-283.2004","article-title":"Immunogenicity of gonococcal transferrin binding proteins during natural infections","volume":"72","author":"Price","year":"2004","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.038_bib34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/smim.1997.0086","article-title":"Challenges for vaccination against sexually transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract","volume":"9","author":"Rosenthal","year":"1997","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.038_bib35","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1128\/IAI.72.3.1775-1785.2004","article-title":"Determination of surface-exposed, functional domains of gonococcal transferrin-binding protein A","volume":"72","author":"Yost-Daljev","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2164-5-23","article-title":"Microarray genomotyping of key experimental strains of Neisseria gonorrhoeae reveals gene complement diversity and five new neisserial genes associated with Minimal Mobile Elements","volume":"5","author":"Snyder","year":"2004","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2180-5-21","article-title":"Strain-specific differences in Neisseria gonorrhoeae associated with the phase variable gene repertoire","volume":"5","author":"Jordan","year":"2005","journal-title":"BMC Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.038_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/plas.1997.1309","article-title":"Construction and characterization of versatile cloning vectors for efficient delivery of native foreign proteins to the periplasm of Escherichia coli","volume":"38","author":"Jobling","year":"1997","journal-title":"Plasmid"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2958.1999.01331.x","article-title":"Identification of sequences in human transferrin that bind to the bacterial receptor protein, transferrin-binding protein B","volume":"32","author":"Retzer","year":"1999","journal-title":"Mol Microbiol"},{"issue":"37","key":"10.1016\/j.vaccine.2007.07.038_bib40","doi-asserted-by":"crossref","first-page":"13584","DOI":"10.1073\/pnas.0405297101","article-title":"A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs","volume":"101","author":"Matoba","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.038_bib41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1286-4579(02)01585-X","article-title":"Humoral immune responses to microbial infections in t he genital tract","volume":"4","author":"Russell","year":"2002","journal-title":"Microbes Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2007.07.038_bib42","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/jb.176.11.3162-3170.1994","article-title":"Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization","volume":"176","author":"Anderson","year":"1994","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-1119(93)90348-7","article-title":"Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2","volume":"130","author":"Legrain","year":"1993","journal-title":"Gene"},{"issue":"29","key":"10.1016\/j.vaccine.2007.07.038_bib44","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.vaccine.2005.02.021","article-title":"Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis","volume":"23","author":"Norheim","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2007.07.038_bib45","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1128\/IAI.68.12.6988-6996.2000","article-title":"Identification of discrete domains within gonococcal transferrin-binding protein A that are necessary for ligand binding and iron uptake functions","volume":"68","author":"Boulton","year":"2000","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.038_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/protein\/gzi024","article-title":"Homology modelling of transferrin-binding protein A from Neisseria meningitidis","volume":"18","author":"Oakhill","year":"2005","journal-title":"Protein Eng Design Select"},{"issue":"13","key":"10.1016\/j.vaccine.2007.07.038_bib47","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0264-410X(95)00055-6","article-title":"Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential","volume":"13","author":"Gorringe","year":"1995","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.038_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1034\/j.1399-3011.2002.21009.x","article-title":"Synthetic peptide epitope-based polymers: controlling size and determining the efficiency of epitope incorporation","volume":"60","author":"Sadler","year":"2002","journal-title":"J Pept Res"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.038_bib49","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1365-2958.1990.tb00673.x","article-title":"Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics","volume":"4","author":"Carbonetti","year":"1990","journal-title":"Mol Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.07.038_bib50","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/IAI.67.11.5699-5708.1999","article-title":"Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice","volume":"67","author":"Jerse","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.07.038_bib51","series-title":"Molecular cloning: a laboratory manual","author":"Maniatis","year":"1982"},{"issue":"22","key":"10.1016\/j.vaccine.2007.07.038_bib52","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1128\/JB.184.22.6138-6145.2002","article-title":"Demonstration and characterization of a specific interaction between gonococcal transferrin binding protein A and TonB","volume":"184","author":"Kenney","year":"2002","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.038_bib53","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/IAI.33.2.555-564.1981","article-title":"Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds","volume":"33","author":"Mickelsen","year":"1981","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.038_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(82)90010-1","article-title":"Pilus expression in Neisseria gonorrhoeae involves chromosomal rearrangement","volume":"30","author":"Meyer","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2007.07.038_bib55","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/169.3.532","article-title":"Human experimentation with Neisseria gonorrhoeae: Rationale, methods, and implications for the biology of infection and vaccine development","volume":"169","author":"Cohen","year":"1994","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T14:19:55Z","timestamp":1683987595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07007955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":55,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07007955"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}